- ￥2826
- R&D Systems
- 131-M1-025/CF
- 美国
- 2025年11月24日
企业认证
相关产品推荐更多 >
Recombinant Mouse CXCL10/IP-10/CRG-2 Protein (10 ug)
￥3502
Recombinant Mouse MMP-12 Protein, CF (20 UG)重组小鼠基质金属蛋白酶-12
￥4583
Recombinant Human BDNF Protein, CF (1 MG)重组小鼠Dkk-2
￥70304
Recombinant Mouse Chordin-Like 2 Protein (50 ug)重组小鼠chordin-Like 2基因
￥5259
Human CCL5 (RANTES) Recombinant Protein, PeproTech®
￥52537
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存：
需确认
- 供应商：
嵘崴达
- 英文名：
Recombinant Human CCL23/MPIF-1 (aa 46-120) Protein, CF (25 ug)
- 规格：
25 µg
致力于向国内生命科学研究人员提供合格产品和完善服务。
主要经营的试剂品牌：
Roche试剂，部分常用现货，周三定货，2-3周到货。
GE试剂，耗材，部分常用现货，周二，周五定货，3周左右。
SIGMA试剂，周一，五定货，3周左右到货。
R&D试剂，周一定货，3-4周到货。
THERMO试剂，部分现货，周三定货，2-3周到货。
ABCAM试剂，国内现货三天左右，期货四周左右。
Peprotech试剂，部分常用现货，周三定货，2-3周到货。
罗氏原料，请来电来邮咨询。
OXOID，BD培养基础货期八周左右，部分现货。
MCE激动剂，ACROS、ALFA、阿拉丁等生化试剂现货定购。
| 131-M1-025/CF | Recombinant Human CCL23/MPIF-1 (aa 46-120) Protein, CF (25 ug) |
| 1320-EN-025 | Recombinant Mouse Endoglin/CD105 Fc Chimera Protein, CF (25 ug) |
| 1324-WN-002 | Recombinant Mouse Wnt-3a Protein (2 ug) |
| 1324-WN-002/CF | Recombinant Mouse Wnt-3a Protein, CF (2 ug) |
| 1324-WN-010 | Recombinant Mouse Wnt-3a Protein (10 ug) |
| 1324-WN-010/CF | Recombinant Mouse Wnt-3a Protein, CF (10 ug) |
| 1324-WN-500/CF | Recombinant Mouse Wnt-3a Protein, CF (500 ug) |
| 1324-WNP-010 | Recombinant Mouse Wnt-3a (High Purity) Protein (10 ug) |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Preparation of Recombinant Protein Spotted Arrays for Proteome‐Wide Identification of Kinase Targets
, M., and Snyder, M. 2011. Diverse protein kinase interactions identified by protein microarrays reveal novel connections between cellular processes. Genes Dev. 25:767‐778.
A recombinant bifunctional fusion protein, consisting of a recombinant antibody and a DNA-binding protein, can be used as a nonviral gene delivery vector (Fig. 1 ). In this lab, such a fusion protein, composed of a human antibody Fab(105
Assessing Fc Glycan Heterogeneity of Therapeutic Recombinant Monoclonal Antibodies Using NP-HPLC
Recombinant monoclonal antibodies (rMAbs) are becoming major human therapeutics to treat life-threatening diseases such as cancer. These rMAbs are produced using either in vitro cell culture processes or transgenic technology in animals
技术资料暂无技术资料 索取技术资料
